These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6686653)

  • 41. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
    Spyraki C; Fibiger HC
    Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.
    Klawans HL; Margolin DI
    Arch Gen Psychiatry; 1975 Jun; 32(6):725-32. PubMed ID: 1130936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopaminergic drugs antagonize the psychotomimetic effects of partial-agonist analgesics.
    Buckett WR; Shaw JS
    Psychopharmacologia; 1975 Jun; 42(3):293-7. PubMed ID: 1172254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further evidence for the neuroleptic-like activity of gamma-endorphin.
    Király I; Tapfer M; Borsy J; Gráf L
    Peptides; 1981; 2(1):9-12. PubMed ID: 6165979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereotypy, locomotor and cataleptic effects produced by drugs influencing dopaminergic systems in a mutant strain of Wistar rats: a genuine model of basal ganglia dysfunction?
    Turski L; Schwarz M; Sontag KH
    Behav Brain Res; 1984 Apr; 12(1):29-37. PubMed ID: 6539616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological evidence for the subclassification of central dopamine receptors in the rat.
    Gower AJ; Marriott AS
    Br J Pharmacol; 1982 Sep; 77(1):185-93. PubMed ID: 6889902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchanged.
    Timar J; Knoll B; Knoll J
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):255-66. PubMed ID: 3103558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of naloxone, metenkephalin, and morphine on phencyclidine-induced behavior in the rat.
    Castellani S; Giannini AJ; Adams PM
    Psychopharmacology (Berl); 1982; 78(1):76-80. PubMed ID: 6815700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity.
    Dewey KJ; Fibiger HC
    Naunyn Schmiedebergs Arch Pharmacol; 1983 May; 322(4):261-70. PubMed ID: 6683359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apomorphine does not alter amphetamine-induced dopamine release measured in striatal dialysates.
    Kuczenski R; Segal DS; Manley LD
    J Neurochem; 1990 May; 54(5):1492-9. PubMed ID: 2324735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
    Davis A; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1990; 100(1):19-26. PubMed ID: 1967499
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NMDA antagonists block expression of sensitization of amphetamine- and apomorphine-induced stereotypy.
    Battisti JJ; Shreffler CB; Uretsky NJ; Wallace LJ
    Pharmacol Biochem Behav; 2000 Oct; 67(2):241-6. PubMed ID: 11124387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
    Cox B; Ary M; Lomax P
    J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cholecystokinin modulation of apomorphine- or amphetamine-induced stereotypy in rats: opposite effects.
    Tieppo CA; Felicio LF; Nasello AG
    Peptides; 2001 Aug; 22(8):1291-8. PubMed ID: 11457523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modification of the development of acute opiate tolerance by increased dopamine receptor sensitivity.
    Martin JR; Takemori AE
    J Pharmacol Exp Ther; 1987 Apr; 241(1):48-55. PubMed ID: 3572795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small doses of apomorphine induce catalepsy and antagonize methamphetamine stereotypy in rats.
    Balsara JJ; Bapat TR; Gada VP; Chandorkar AG
    Psychopharmacology (Berl); 1982; 78(2):192-4. PubMed ID: 6817377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
    Clark D; Furmidge LJ; Petry N; Tong ZY; Ericsson M; Johnson D
    Psychopharmacology (Berl); 1991; 105(3):381-92. PubMed ID: 1686815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of L-histidine and chlorcyclizine on apomorphine-induced climbing behaviour and methamphetamine stereotypy in mice.
    Joshi VV; Balsara JJ; Jadhav JH; Chandorkar AG
    Eur J Pharmacol; 1981 Feb; 69(4):499-502. PubMed ID: 6113966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of opiates with dopamine receptors: receptor binding and behavioral assays.
    Carlson KR; Seeger TF
    Pharmacol Biochem Behav; 1982 Jan; 16(1):119-24. PubMed ID: 6173883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.